Northwest Biotherapeutics (NWBO) Assets: 2009-2025
Historic Assets for Northwest Biotherapeutics (NWBO) over the last 17 years, with Sep 2025 value amounting to $30.6 million.
- Northwest Biotherapeutics' Assets rose 4.39% to $30.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.6 million, marking a year-over-year increase of 4.39%. This contributed to the annual value of $26.7 million for FY2024, which is 4.08% down from last year.
- Northwest Biotherapeutics' Assets amounted to $30.6 million in Q3 2025, which was up 3.59% from $29.5 million recorded in Q2 2025.
- Over the past 5 years, Northwest Biotherapeutics' Assets peaked at $40.2 million during Q4 2021, and registered a low of $26.7 million during Q4 2024.
- Over the past 3 years, Northwest Biotherapeutics' median Assets value was $28.6 million (recorded in 2024), while the average stood at $29.2 million.
- As far as peak fluctuations go, Northwest Biotherapeutics' Assets surged by 253.48% in 2021, and later decreased by 22.00% in 2022.
- Quarterly analysis of 5 years shows Northwest Biotherapeutics' Assets stood at $40.2 million in 2021, then dropped by 22.00% to $31.3 million in 2022, then declined by 11.04% to $27.9 million in 2023, then dropped by 4.08% to $26.7 million in 2024, then climbed by 4.39% to $30.6 million in 2025.
- Its Assets was $30.6 million in Q3 2025, compared to $29.5 million in Q2 2025 and $27.5 million in Q1 2025.